AKYNZEO caps 300mg/0.5mg
7680654990013
CH-65499
A04AA55
01.09.0.
Reimbursement limitations:
AKYNZEO
Associé à la dexaméthasone chez l’adulte pour:
- la prévention des nausées et vomissements aigus …
1 / 3
google
Details
- Product number
- 6549901
- CPT
- -
- Packaging group
- 1
- Unit
- Kapsel(n)
- Composition
- netupitantum 300 mg, palonosetronum 0.5 mg ut palonosetroni hydrochloridum, cellulosum microcristallinum, sacchari lauras corresp. saccharum 20 mg, povidonum K 30, carmellosum natricum conexum, silica colloidalis hydrica, natrii stearylis fumaras, magnesii stearas, macrogol 6 glyceroli caprylocapras, glycerolum, polyglyceroli-3 mono-oleas, aqua purificata, E 320, Kapselhülle: gelatina, sorbitolum 7 mg, 1,4-sorbitanum, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum pro capsula corresp. natrium 0.38 mg.
Articles (1)
Akynzeo 300 mg/0.5 mg, Kapseln
Kapseln
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
20.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | ANTOX |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
7.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.38 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 97.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/01/2016
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 65499
- Drug name
- Akynzeo, Kapseln
- Galenic form
- KAPS
- ATC Code
- A04AA55
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 06/11/2015
- Authorization expiration date
- 31/12/9999
- IT number
- 01.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AKYNZEO caps 300mg/0.5mg
- Description (DE)
- AKYNZEO Kaps 300mg/0.5mg
- Market launch
- 06/11/2015
- Narcotic (BTM)
- No